The glomerular filtration barrier: Components and crosstalk

International Journal of Nephrology

Volumn 2012, Issue , 2012, Pages

  Menon, Madhav C ^a   Chuang, Peter Y ^a   He, Cijiang John ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866269452     PISSN: 2090214X     EISSN: 20902158     Source Type: Journal    
DOI: 10.1155/2012/749010     Document Type: Review

References (85)

1. Peterson J. C., Adler S., Burkart J. M., Greene T., Hebert L. A., Hunsicker L. G., King A. J., Klahr S., Massry S. G., Seifter J. L., Blood pressure control, proteinuria, and the progression of renal disease: the modification of diet in renal disease study. Annals of Internal Medicine 1995 123 10 754 762 2-s2.0-0028838569
2. Chronic Kidney Disease Prognosis C., Matsushita K., van der Velde M., Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. The Lancet 2010 375 9731 2073 2081
3. Carroll M. F., Temte J. L., Proteinuria in adults: a diagnostic approach. American Family Physician 2000 62 6 1333 1340 2-s2.0-0034665040
4. Barratt J., Topham P., Urine proteomics: the present and future of measuring urinary protein components in disease. Canadian Medical Association Journal 2007 177 4 361 368 2-s2.0-34548359247 10.1503/Canadian Medical Association Journal.061590
5. Russo L. M., Sandoval R. M., McKee M., Osicka T. M., Collins A. B., Brown D., Molitoris B. A., Comper W. D., The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney International 2007 71 6 504 513 2-s2.0-33947181051 10.1038/sj.ki.5002041
6. Tanner G. A., Glomerular sieving coefficient of serum albumin in the rat: a two-photon microscopy study. American Journal of Physiology 2009 296 6 F1258 F1265 2-s2.0-66449127382 10.1152/ajprenal.90638.2008
7. Peti-Peterdi J., Independent two-photon measurements of albumin GSC give low values. American Journal of Physiology 2009 296 6 F1255 F1257 2-s2.0-66449104944 10.1152/ajprenal.00144.2009
8. Tojo A., Endou H., Intrarenal handling of proteins in rats using fractional micropuncture technique. American Journal of Physiology 1992 263 4 F601 F606 2-s2.0-0026445848
9. Pavenstädt H., Kriz W., Kretzler M., Cell biology of the glomerular podocyte. Physiological Reviews 2003 83 1 253 307 2-s2.0-0037207471
10. D'Agati V. D., Kaskel F. J., Falk R. J., Focal segmental glomerulosclerosis. The New England Journal of Medicine 2011 365 25 2398 2411 10.1056/NEJMra1106556
11. Hudson B. G., Tryggvason K., Sundaramoorthy M., Neilson E. G., Alport's syndrome, Goodpasture's syndrome, and type IV collagen. The New England Journal of Medicine 2003 348 25 2543 2556 2-s2.0-0038469583 10.1056/NEJMra022296
12. Noris M., Remuzzi G., Atypical hemolytic-uremic syndrome. The New England Journal of Medicine 2009 361 17 1676 1687 2-s2.0-70350279315
13. Ambrus J. L. Jr., Sridhar N. R., Immunologic aspects of renal disease. Journal of the American Medical Association 1997 278 22 1938 1945 2-s2.0-0031467505
14. Kerjaschki D., Sharkey D. J., Farquhar M. G., Identification and characterization of podocalyxinthe major sialoprotein of the renal glomerular epithelial cell. Journal of Cell Biology 1984 98 4 1591 1596 2-s2.0-0021262325
15. Schnabel E., Anderson J. M., Farquhar M. G., The tight junction protein ZO-1 is concentrated along slit diaphragms of the glomerular epithelium. Journal of Cell Biology 1990 111 3 1255 1263 2-s2.0-0025008077 10.1083/jcb.111.3.1255
16. Reiser J., Kriz W., Kretzler M., Mundel P., The glomerular slit diaphragm is a modified adherens junction. Journal of the American Society of Nephrology 2000 11 1 1 8 2-s2.0-0033958396
17. Ruotsalainen V., Ljungberg P., Wartiovaara J., Lenkkeri U., Kestila M., Jalanko H., Holmberg C., Tryggvason K., Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proceedings of the National Academy of Sciences of the United States of America 1999 96 14 7962 7967 2-s2.0-0033529312 10.1073/pnas.96.14.7962
18. Wartiovaara J., Öfverstedt L. G., Khoshnoodi J., Zhang J., Mäkelä E., Sandin S., Ruotsalainen V., Cheng R. H., Jalanko H., Skoglund U., Tryggvason K., Nephrin strands contribute to a porous slit diaphragm scaffold as revealed by electron tomography. Journal of Clinical Investigation 2004 114 12, article 1820 2-s2.0-20144366700 10.1172/ JCI200422562C1
19. Liu G., Kaw B., Kurfis J., Rahmanuddin S., Kanwar Y. S., Chugh S. S., Neph1 and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability. Journal of Clinical Investigation 2003 112 2 209 221 2-s2.0-0042242818 10.1172/JCI200318242
20. Kaplan J. M., Kim S. H., North K. N., Rennke H., Correia L. A., Tong H. Q., Mathis B. J., Rodríguez-Pérez J. C., Allen P. G., Beggs A. H., Pollak M. R., Mutations in ACTN4, encoding α -actinin-4, cause familial focal segmental glomerulosclerosis. Nature Genetics 2000 24 3 251 256 2-s2.0-0034051681 10.1038/73456
21. Brown E. J., Schlöndorff J. S., Becker D. J., Tsukaguchi H., Uscinski A. L., Higgs H. N., Henderson J. M., Pollak M. R., Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nature Genetics 2010 42 1 72 76 2-s2.0-73349132341 10.1038/ng.505
22. Ma H., Togawa A., Soda K., Zhang J., Lee S., Ma M., Yu Z., Ardito T., Czyzyk J., Diggs L., Joly D., Hatakeyama S., Kawahara E., Holzman L., Guan J. L., Ishibe S., Inhibition of podocyte FAK protects against proteinuria and foot process effacement. Journal of the American Society of Nephrology 2010 21 7 1145 1156 2-s2.0-77954599877 10.1681/ASN.2009090991
23. Branten A. J. W., Van den Born J., Jansen J. L. J., Assmann K. J. M., Wetzels J. F. M., Dijkman H. B. P. M., Familial nephropathy differing from minimal change nephropathy and focal glomerulosclerosis. Kidney International 2001 59 2 693 701 2-s2.0-0035132560 10.1046/j.1523-1755.2001.059002693.x
24. Macconi D., Ghilardi M., Bonassi M. E., Mohamed E. I., Abbate M., Colombi F., Remuzzi G., Remuzzi A., Effect of angiotensin-converting enzyme inhibition on glomerular basement membrane permeability and distribution of zonula occludens-1 in MWF rats. Journal of the American Society of Nephrology 2000 11 3 477 489 2-s2.0-0034094361
25. Karumanchi S. A., Maynard S. E., Stillman I. E., Epstein F. H., Sukhatme V. P., Preeclampsia: a renal perspective. Kidney International 2005 67 6 2101 2113 2-s2.0-23044517421 10.1111/j.1523-1755.2005.00316.x
26. Wharram B. L., Goyal M., Gillespie P. J., Wiggins J. E., Kershaw D. B., Holzman L. B., Dysko R. C., Saunders T. L., Samuelson L. C., Wiggins R. C., Altered podocyte structure in GLEPP1 (Ptpro)-deficient mice associated with hypertension and low glomerular filtration rate. Journal of Clinical Investigation 2000 106 10 1281 1290 2-s2.0-0033722475
27. van den Berg J. G., van den Bergh Weerman M. A., Assmann K. J. M., Weening J. J., Florquin S., Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney International 2004 66 5 1901 1906 2-s2.0-15944387124 10.1111/j.1523-1755.2004.00964.x
28. Seiler M. W., Venkatachalam M. A., Cotran R. S., Glomerular epithelium: structural alterations induced by polycations. Science 1975 189 4200 390 393 2-s2.0-0016808475
29. Garg P., Verma R., Cook L., Soofi A., Venkatareddy M., George B., Mizuno K., Gurniak C., Witke W., Holzman L. B., Actin-depolymerizing factor cofilin-1 is necessary in maintaining mature podocyte architecture. Journal of Biological Chemistry 2010 285 29 22676 22688 2-s2.0-77954609124 10.1074/jbc.M110.122929
30. Kim J. H., Wu H., Green G., Winkler C. A., Kopp J. B., Miner J. H., Unanue E. R., Shawl A. S., CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 2003 300 5623 1298 1300 2-s2.0-0038136885 10.1126/science.1081068
31. Wei C., Reiser J., Minimal change disease as a modifiable podocyte paracrine disorder. Nephrology Dialysis Transplantation 2011 26 6 1776 1777 2-s2.0-79958124668 10.1093/ndt/gfr124
32. Garg P., Rabelink T., Glomerular proteinuria: a complex interplay between unique players. Advances in Chronic Kidney Disease 2011 18 4 233 242 2-s2.0-79960517720 10.1053/j.ackd.2011.06.001
33. Reiser J., Oh J., Shirato I., Asanuma K., Hug A., Mundel T. M., Honey K., Ishidoh K., Kominami E., Kreidberg J. A., Tomino Y., Mundel P., Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and α 3 integrin. Journal of Biological Chemistry 2004 279 33 34827 34832 2-s2.0-4544377833 10.1074/jbc.M401973200
34. Adler S., Chen X., Anti-Fx1A antibody recognizes a β 1-integrin on glomerular epithelial cells and inhibits adhesion and growth. American Journal of Physiology 1992 262 5 F770 F776 2-s2.0-0026647670
35. El-Aouni C., Herbach N., Blattner S. M., Henger A., Rastaldi M. P., Jarad G., Miner J. H., Moeller M. J., St.-Arnaud R. R., Dedhar S., Holzman L. B., Wanke R., Kretzler M., Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis. Journal of the American Society of Nephrology 2006 17 5 1334 1344 2-s2.0-33646356720 10.1681/ASN.2005090921
36. Kang Y. S., Li Y., Dai C., Kiss L. P., Wu C., Liu Y., Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney International 2010 78 4 363 373 2-s2.0-77955172248 10.1038/ki.2010.137
37. Blasi F., Carmeliet P., uPAR: a versatile signalling orchestrator. Nature Reviews Molecular Cell Biology 2002 3 12 932 943 2-s2.0-0036906177 10.1038/nrm977
38. Smith H. W., Marshall C. J., Regulation of cell signalling by uPAR. Nature Reviews Molecular Cell Biology 2010 11 1 23 36 10.1038/nrm2821
39. Wei C., Moller C. C., Altintas M. M., Modification of kidney barrier function by the urokinase receptor. Nature Medicine 2008 14 1 55 63 10.1038/nm1696
40. Wei C., El Hindi S., Li J., Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nature Medicine 2011 17 8 952 960 10.1038/nm.2411
41. Striker G. E., Smuckler E. A., An ultrastructural study of glomerular basement membrane synthesis. American Journal of Pathology 1970 58 3 531 565 2-s2.0-0014750812
42. Abrahamson D. R., Structure and development of the glomerular capillary wall and basement membrane. American Journal of Physiology 1987 253 5 F783 F794 2-s2.0-0023470854
43. Sanes J. R., Engvall E., Butkowski R., Hunter D. D., Molecular heterogeneity of basal laminae: isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere. Journal of Cell Biology 1990 111 4 1685 1699 2-s2.0-0025010542
44. Kalluri R., Cosgrove D., Assembly of Type IV collagen. Insights from α 3(IV) collagen-deficient mice. Journal of Biological Chemistry 2000 275 17 12719 12724 2-s2.0-0034724892 10.1074/jbc.275.17.12719
45. Zenker M., Aigner T., Wendler O., Tralau T., Müntefering H., Fenski R., Pitz S., Schumacher V., Royer-Pokora B., Wühl E., Cochat P., Bouvier R., Kraus C., Mark K., Madlon H., Dötsch J., Rascher W., Maruniak-Chudek I., Lennert T., Neumann L. M., Reis A., Human laminin β 2 deficiency causes congenital nephrosis with mesangial sclerosis and distinct eye abnormalities. Human Molecular Genetics 2004 13 21 2625 2632 2-s2.0-8444221929 10.1093/hmg/ddh284
46. Noakes P. G., Miner J. H., Gautam M., Cunningham J. M., Sanes J. R., Merlie J. P., The renal glomerulus of mice lacking S-laminin/laminin β 2: nephrosis despite molecular compensation by laminin β 1. Nature Genetics 1995 10 4 400 406 2-s2.0-0029127384
47. Reeves W. H., Kanwar Y. S., Gist Farquhar M., Assembly of the glomerular filtration surface. Differentiation of anionic sites in glomerular capillaries of newborn rat kidney. Journal of Cell Biology 1980 85 3 735 753 2-s2.0-0019302981
48. Kanwar Y. S., Farquhar M. G., Anionic sites in the glomerular basement membrane. In vivo and vitro localization to the laminae rarae by cationic probes. Journal of Cell Biology 1979 81 1 137 153 2-s2.0-0018425671
49. Kanwar Y. S., Linker A., Farquhar M. G., Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. Journal of Cell Biology 1980 86 2 688 693 2-s2.0-0019304713
50. Bolton G. R., Deen W. M., Daniels B. S., Assessment of the charge selectivity of glomerular basement membrane using Ficoll sulfate. American Journal of Physiology 1998 274 5 F889 F896 2-s2.0-0031804133
51. Daniels B. S., Increased albumin permeability in vitro following alterations of glomerular charge is mediated by the cells of the filtration barrier. Journal of Laboratory and Clinical Medicine 1994 124 2 224 230 2-s2.0-0028487983
52. Guasch A., Deen W. M., Myers B. D., Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans. Journal of Clinical Investigation 1993 92 5 2274 2282 2-s2.0-0027362463
53. Chen S., Wassenhove-McCarthy D. J., Yamaguchi Y., Holzman L. B., Van Kuppevelt T. H., Jenniskens G. J., Wijnhoven T. J., Woods A. C., McCarthy K. J., Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria. Kidney International 2008 74 3 289 299 2-s2.0-47349084411 10.1038/ki.2008.159
54. Clement L. C., Avila-Casado C., MacÉ C., Soria E., Bakker W. W., Kersten S., Chugh S. S., Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nature Medicine 2011 17 1 117 122 2-s2.0-78651252297 10.1038/nm.2261
55. Ballermann B. J., Contribution of the endothelium to the glomerular permselectivity barrier in health and disease. Nephron 2007 106 2 p19 p25 2-s2.0-34250339727 10.1159/000101796
56. Jeansson M., Haraldsson B., Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes. Journal of the American Society of Nephrology 2003 14 7 1756 1765 2-s2.0-0037530611 10.1097/01.ASN.0000072742.02714.6E
57. Hjalmarsson C., Johansson B. R., Haraldsson B., Electron microscopic evaluation of the endothelial surface layer of glomerular capillaries. Microvascular Research 2004 67 1 9 17 2-s2.0-0346728703 10.1016/j.mvr.2003.10. 001
58. Fridén V., Oveland E., Tenstad O., Ebefors K., Nyström J., Nilsson U. A., Haraldsson B., The glomerular endothelial cell coat is essential for glomerular filtration. Kidney International 2011 79 12 1322 1330 2-s2.0-79957801362 10.1038/ki.2011.58
59. Kerr H., Richards A., Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome. Immunobiology 2012 217 2 195 203 10.1016/j.imbio.2011.07.028
60. Besbas N., Karpman D., Landau D., Loirat C., Proesmans W., Remuzzi G., Rizzoni G., Taylor C. M., Van De Kar N., Zimmerhackl L. B., A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders. Kidney International 2006 70 3 423 431 2-s2.0-33746508999 10.1038/sj.ki.5001581
61. Manuelian T., Hellwage J., Meri S., Caprioli J., Noris M., Heinen S., Jozsi M., Neumann H. P. H., Remuzzi G., Zipfel P. F., Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. Journal of Clinical Investigation 2003 111 8 1181 1190 2-s2.0-0037396993 10.1172/JCI200316651
62. Heinen S., Józsi M., Hartmann A., Noris M., Remuzzi G., Skerka C., Zipfel P. F., Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells. Journal of the American Society of Nephrology 2007 18 2 506 514 2-s2.0-33846668749 10.1681/ASN.2006091069
63. Richards A., Kemp E. J., Liszewski M. K., Goodship J. A., Lampe A. K., Decorte R., Müslümanolu M. H., Kavukcu S., Filler G., Pirson Y., Wen L. S., Atkinson J. P., Goodship T. H. J., Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome. Proceedings of the National Academy of Sciences of the United States of America 2003 100 22 12966 12971 2-s2.0-0242331610 10.1073/pnas.2135497100
64. Foster R. R., Hole R., Anderson K., Satchell S. C., Coward R. J., Mathieson P. W., Gillatt D. A., Saleem M. A., Bates D. O., Harper S. J., Functional evidence that vascular endothelial growth factor may act as an autocrine factor on human podocytes. American Journal of Physiology 2003 284 6 F1263 F1273 2-s2.0-0038623780
65. Eremina V., Quaggin S. E., The role of VEGF-A in glomerular development and function. Current Opinion in Nephrology and Hypertension 2004 13 1 9 15 2-s2.0-3242749316 10.1097/00041552-200401000-00002
66. Sison K., Eremina V., Baelde H., Min W., Hirashima M., Fantus I. G., Quaggin S. E., Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling. Journal of the American Society of Nephrology 2010 21 10 1691 1701 2-s2.0-77957861954 10.1681/ASN.2010030295
67. Eremina V., Sood M., Haigh J., Nagy A., Lajoie G., Ferrara N., Gerber H. P., Kikkawa Y., Miner J. H., Quaggin S. E., Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. Journal of Clinical Investigation 2003 111 5 707 716 2-s2.0-0037370325 10.1172/JCI200317423
68. Maynard S. E., Min J. Y., Merchan J., Lim K. H., Li J., Mondal S., Libermann T. A., Morgan J. P., Sellke F. W., Stillman I. E., Epstein F. H., Sukhatme V. P., Karumanchi S. A., Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction hypertension, and proteinuria in preeclampsia. Journal of Clinical Investigation 2003 111 5 649 658 2-s2.0-0037373006 10.1172/JCI200317189
69. Eremina V., Jefferson J. A., Kowalewska J., Hochster H., Haas M., Weisstuch J., Richardson C., Kopp J. B., Kabir M. G., Backx P. H., Gerber H. P., Ferrara N., Barisoni L., Alpers C. E., Quaggin S. E., VEGF inhibition and renal thrombotic microangiopathy. The New England Journal of Medicine 2008 358 11 1129 1136 2-s2.0-40849130173 10.1056/NEJMoa0707330
70. Presta L. G., Chen H., O'Connor S. J., Chisholm V., Meng Y. G., Krummen L., Winkler M., Ferrara N., Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Research 1997 57 20 4593 4599 2-s2.0-0030856731
71. Zhu X., Wu S., Dahut W. L., Parikh C. R., Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. American Journal of Kidney Diseases 2007 49 2 186 193 2-s2.0-33846638744 10.1053/j.ajkd.2006.11.039
72. Izzedine H., Brocheriou I., Deray G., Rixe O., Thrombotic microangiopathy and anti-VEGF agents. Nephrology Dialysis Transplantation 2007 22 5 1481 1482 2-s2.0-34447520277 10.1093/ndt/gfl565
73. Takabatake Y., Sugiyama T., Kohara H., Matsusaka T., Kurihara H., Koni P. A., Nagasawa Y., Hamano T., Matsui I., Kawada N., Imai E., Nagasawa T., Rakugi H., Isaka Y., The CXCL12 (SDF-1)/CXCR4 axis is essential for the development of renal vasculature. Journal of the American Society of Nephrology 2009 20 8 1714 1723 2-s2.0-68049123542 10.1681/ASN.2008060640
74. Petruzziello-Pellegrini T. N., Yuen D. A., Page A. V., The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice. Journal of Clinical Investigation 2012 122 2 759 776 10.1172/JCI57313
75. Schlöndorff D., Roles of the mesangium in glomerular function. Kidney International 1996 49 6 1583 1585 2-s2.0-0029938272
76. Leveen P., Pekny M., Gebre-Medhin S., Swolin B., Larsson E., Betsholtz C., Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes and Development 1994 8 16 1875 1887 2-s2.0-0027936261
77. Soriano P., Abnormal kidney development and hematological disorders in PDGF β-receptor mutant mice. Genes and Development 1994 8 16 1888 1896 2-s2.0-0028059309
78. Yamamoto T., Mundy C. A., Wilson C. B., Blantz R. C., Effect of mesangial cell lysis and proliferation on glomerular hemodynamics in the rat. Kidney International 1991 40 4 705 713 2-s2.0-0025947181
79. Buschhausen L., Seibold S., Gross O., Matthaeus T., Weber M., Schulze-Lohoff E., Regulation of mesangial cell function by vasodilatory signaling molecules. Cardiovascular Research 2001 51 3 463 469 2-s2.0-0035882440 10.1016/S0008-6363(01)00340-6
80. Ziyadeh F. N., Sharma K., Ericksen M., Wolf G., Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor- β Journal of Clinical Investigation 1994 93 2 536 542 2-s2.0-0028218461
81. Zheng F., Cornacchia F., Schulman I., Banerjee A., Cheng Q. L., Potier M., Rita Plati A., Berho M., Elliot S. J., Li J., Fornoni A., Zang Y. J., Zisman A., Striker L. J., Striker G. E., Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors. Diabetes 2004 53 9 2420 2427 2-s2.0-4344672420 10.2337/diabetes.53.9.2420
82. Tomana M., Novak J., Julian B. A., Matousovic K., Konecny K., Mestecky J., Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. Journal of Clinical Investigation 1999 104 1 73 81 2-s2.0-0032695357
83. Lai K. N., Tang S. C. W., Guh J. Y., Chuang T. D., Lam M. F., Chan L. Y. Y., Tsang A. W. L., Leung J. C. K., Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor- β synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. Journal of the American Society of Nephrology 2003 14 12 3127 3137 2-s2.0-0344667757 10.1097/01.ASN.0000095639.56212.BF
84. Lai K. N., Leung J. C. K., Chan L. Y. Y., Saleem M. A., Mathieson P. W., Lai F. M., Tang S. C. W., Activation of podocytes by mesangial-derived TNF- α: glomerulo-podocytic communication in IgA nephropathy. American Journal of Physiology 2008 294 4 F945 F955 2-s2.0-44949252210 10.1152/ajprenal.00423. 2007
85. Del Prete D., Gambaro G., Lupo A., Anglani F., Brezzi B., Magistroni R., Graziotto R., Furci L., Modena F., Bernich P., Albertazzi A., D'Angelo A., Maschio G., Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. Kidney International 2003 64 1 149 159 2-s2.0-12444323017 10.1046/j.1523-1755.2003.00065.x